Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0000950170-25-063840

President, CEO and CFO bought 5,000 shares at an average $0.57 ($2,835)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Quinn William P. President, CEO and CFO 2024-12-16 Purchase +2,500 $0.50 $1,241 41,272 D: show line 1 in the form
Quinn William P. President, CEO and CFO 2024-06-06 Purchase +2,500 $0.64 $1,594 38,772 D: show line 2 in the form
Open-market purchases · 5,000 sh · avg $0.57 · $2,835

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Quinn William P. President, CEO and CFO 2025-05-01 Grant or award · Stock Option (Right to Buy) +700,000 700,000 D: show line 3 in the form
Loading xslF345X05/ownership.xml…